Global Inhaled Nitric Oxide Market was valued at USD XX million in 2019 and expected to grow with a CAGR 8.1% over the forecasting period 2020-2027. Inhaled Nitric Oxide (INO) is a gas which inhaled through mouth. It is used together with ventilator machine and other machines which work in muscles smoothening to widen the blood vessels in the lungs. INO is identified as an intoxicating and selective pulmonary vasodilator that does not decrease systemic vascular tone. Increase in chronic diseases, accelerates the demand of INO in healthcare sector thus, driving the market growth of the global Inhaled Nitric Oxide market. Moreover, ncreasing number of patients with chronic obstructive pulmonary disease and increasing occurrence of diseases in the new-born babies such as neonatal hypoxic respiratory failure (HRF) and persistent pulmonary hypertension also enhanced the market growth. For Instance, as per JHEOR 2019 report ((Journal of Health Economics and Outcomes Research), the annual number of term and late pre-term new-borns with HRF is projected at 80000 in the United State alone. Despite that, strict application norms and High cost of treatment are hindering the growth of market over the forecasting period 2020-2027.
The regional analysis of the Inhaled Nitric Oxide Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. In which, North America is dominating region. Growing respiratory disease and asthma incidence was highest among workers in the healthcare and social assistance industry. However, APAC is emerged as fastest growing region over the forecasting period 2020-2027 due to highest live birth per 1000 people and increasing respiratory diseases.


Key Players in Global Inhaled Nitric Oxide Market
Air Liquide Healthcare
Mallinckrodt
Matheson Tri-Gas Inc.
Merck KGaA
Novoteris
Nu-Med Plus
Perma Pure LLC
Praxair Technology Inc.
Beyond Air Inc.
Linde Plc (Praxair Inc.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Gas
Delivery Systems

By Application:
Neonatal Respiratory Treatment
Asthma and COPD (Chronic obstructive pulmonary disease)
Acute Respiratory Distress Syndrome (ARDS)
Malaria Treatment
Tuberculosis Treatment
Other Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy


Asia Pacific
China
India
Japan
Australia


Latin America
Brazil
Mexico
Rest of LA
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027

Target Audience of Global Inhaled Nitric Oxide Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors